CRISPR Therapeutics begins natural killer cell cancer tie-up with Nkarta
pharmaphorum
MAY 7, 2021
Founded by Nobel prize winner Emmanuelle Charpentier, CRISPR Therapeutics has been at the forefront of the gene editing technology and has refined it to the point where it can be used to accurately edit DNA to correct genetic conditions or modify cells to fight disease.
Let's personalize your content